U.S. Government Must Invest More In Developing Multipurpose Prevention Technologies, Paper Says

Guttmacher Institute: Multipurpose prevention technologies hold great promise, but more U.S. investment is necessary to make them a reality
This press release discusses a new analysis by Heather Boonstra, director of public policy at the Guttmacher Institute, on multipurpose prevention technologies (MPTs), which are “products that simultaneously protect against multiple risks, such as unintended pregnancy, HIV, and other STIs. … ‘Supporting and adequately funding the development of MPTs should be a higher priority for the U.S. government, especially at a time when private sector support is missing,’ says Boonstra…” (9/15).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.